Drug resistance pattern
|
New cases (N = 85)
|
Re-treated cases (N-21)
|
Total (N = 106)
|
---|
n (%) (95 % CI)
|
n (%) (95 % CI)
|
n (%) 95 % CI
|
---|
Any R to one drug
|
13 (15.2 % (7.6–22.8)
|
11 (52.3: 30.9–73.7)
|
24 (22.6: 14.6–30.6)
|
Any INH
|
8 (9.4 %)
|
6 (28.6)
|
14 (13.2)
|
Any RIF
|
4 (4.7)
|
4 (19.0)
|
8 (7.5)
|
Any STM
|
8 (9.4)
|
5 (23.8)
|
13 (12.3)
|
Any EMB
|
3 (3.5)
|
2 (9.5)
|
5 (4.7)
|
Mono resistance
|
4
|
4
|
8
|
Only INH
|
2 (2.4)
|
1 (4.8)
|
3 (2.8)
|
Only RIF
|
0
|
0
|
0
|
Only STM
|
2 (2.4)
|
2 (9.5)
|
4 (3.8)
|
Only EMB
|
0
|
1 (4.8)
|
1
|
Two-drug resistance
|
7
|
4
|
11
|
INH + RIF
|
1 (1.2)*
|
1 (4.8)
|
2 (1.9)*
|
INH + ETM
|
1 (1.2)
|
0
|
1 (0.9)
|
INH + STM
|
2 (2.4)
|
2 (9.5)
|
4 (3.8)
|
RIF + EMB
|
0
|
0
|
0
|
RIF + STM
|
2 (2.4)
|
1 (4.8)
|
3 (2.8)
|
ETM + STM
|
1 (1.2)
|
0
|
1 (0.9)
|
Three or more-drug resistance
|
2
|
3
|
5
|
INH + RIF + EMB
|
0
|
0
|
0
|
INH + RIF + STM
|
1 (1.2)*
|
2 (9.5)
|
3 (2.8)*
|
INH + EMB + STM
|
1 (1.2)
|
0
|
1 (0.9)
|
RIF + ETM + STM
|
0
|
0
|
0
|
INH + RIF + EMB + STM
|
0
|
1 (5.9)
|
1 (0.9)
|
MDR*
|
2 (2.4)
|
3 (14.3)
|
5 (4.7)
|
- NB: MDR-TB* is multi-drug resistant TB